EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Conditions
COVID-19
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Phoenix Children's Hospital, Phoenix, Arizona, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Kaiser Permanente, Los Angeles, California, United States
UCLA David Geffen School of Medicine, Los Angeles, California, United States
UCLA, Los Angeles, California, United States
Children's National Medical Center, Washington D.C., District of Columbia, United States
Life Spring Research Foundation, Miami, Florida, United States
Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta, Georgia, United States
Rophe Adult and Pediatric Medicine/SKYCRNG, Union City, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Louisiana State University Health Sciences Shreveport, Shreveport, Louisiana, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Boston Medical Center, Boston, Massachusetts, United States
University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
Childrens Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States
SKY Integrative Medical Center/SKYCRNG, Ridgeland, Mississippi, United States
St. Louis Children's Hospital, St Louis, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Children's Hospital & Medical Center, Omaha, Nebraska, United States
University of New Mexico Hospital, COVID-19 Research Clinic, Albuquerque, New Mexico, United States
University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States
Suny University at Buffalo, Buffalo, New York, United States
Advanced Specialty Care, Commack, New York, United States
Stony Brook Medicine Clinical Research Center, East Setauket, New York, United States
Cohen Children's Medical Center, New Hyde Park, New York, United States
Columbia University Irving Medical Center, New York, New York, United States
Stony Brook University, Stony Brook, New York, United States
Upstate Health Care Center, Syracuse, New York, United States
Crouse Physicians Office Building, Syracuse, New York, United States
SUNY Upstate Medical University, Syracuse, New York, United States
Upstate Golisano Children's Hospital, Syracuse, New York, United States
Clinical and Translational Research Center, Chapel Hill, North Carolina, United States
investigational Drug Services Pharmacy, UNC Hospitals, Chapel Hill, North Carolina, United States
UNC Children's Hospital, Chapel Hill, North Carolina, United States
UNC Global Clinical Research North, Chapel Hill, North Carolina, United States
University of North Carolina Medical Center, Chapel Hill, North Carolina, United States
UNC Children's Raleigh, Raleigh, North Carolina, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
UH Landerbrook Health Center, Mayfield Heights, Ohio, United States
UH Parma Medical Center, Parma, Ohio, United States
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Rhode Island Hospital, Providence, Rhode Island, United States
The Miriam Hospital-Clinical Trials, Providence, Rhode Island, United States
Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, United States
Avera Research Institute - Sioux Falls, Sioux Falls, South Dakota, United States
Texas Children's Hospital, Houston, Texas, United States
Biopharma Informatic, LLC, McAllen, Texas, United States
Consano Clinical Research, LLC, Shavano Park, Texas, United States
University of Utah, Salt Lake City, Utah, United States
МHAT "Sveti Ivan Rilski" Gorna Oryahovitsa, Gorna Oryahovitsa, Bulgaria
"Specialized Hospital for Active Treatment of Pneumo-Physiatric Diseases Dr. Dimitar Gramatikov -, Rousse, Bulgaria
Medical Center-1-Sevlievo EOOD, Sevlievo, Bulgaria
DCC "Alexandrovska", Sofia, Bulgaria
Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Vratsa EOOD, Vratsa, Bulgaria
Tokyo Metropolitan Children's Medical Center, Fuchū, Tokyo, Japan
Osaka City General Hospital, Osaka, Japan
Instituto Nacional de Pediatria, Mexico City, Mexico City, Mexico
Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico City, Mexico
JM Research SC, Cuernavaca, Morelos, Mexico
Fundación Santos y De la Garza Evia, Monterrey, Nuevo León, Mexico
Eukarya Pharmasite S.C., Monterrey, Nuevo León, Mexico
Unidad de Atención Médica e Investigación en Salud, Mérida, Yucatán, Mexico
Kohler & Milstein Research S.A. De C.V., Mérida, Yucatán, Mexico
Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatán S., Mérida, Yucatán, Mexico
Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico
Arké SMO S.A de C.V, Veracruz, Mexico
Sociedad de Metabolismo y Corazon S.C., Veracruz, Mexico
San Miguel Medical, Trujillo Alto, Puerto Rico
Worthwhile Clinical Trials, Benoni, Gauteng, South Africa
CRISMO Research Centre, Germiston, Gauteng, South Africa
Botho Ke Bontle Health Services, Pretoria, Gauteng, South Africa
St. George's Hospital, London, England, United Kingdom
Study leads
Pfizer CT.gov Call Center
Study Director
Pfizer